Filing Details
- Accession Number:
- 0001062993-21-007078
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-05 12:38:21
- Reporting Period:
- 2021-08-04
- Accepted Time:
- 2021-08-05 12:38:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 12208 | Bio-Rad Laboratories Inc. | BIO BIOB | Laboratory Analytical Instruments (3826) | 941381833 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446964 | Ilan Daskal | C/O Bio-Rad Laboratories, Inc. 1000 Alfred Nobel Drive Hercules CA 94547 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | Acquisiton | 2021-08-04 | 1,400 | $309.84 | 2,307 | No | 4 | M | Direct | |
| Bio-Rad A Common Stock | Disposition | 2021-08-04 | 857 | $750.85 | 1,450 | No | 4 | S | Direct | |
| Bio-Rad A Common Stock | Disposition | 2021-08-04 | 954 | $751.98 | 496 | No | 4 | S | Direct | |
| Bio-Rad A Common Stock | Disposition | 2021-08-04 | 489 | $753.32 | 7 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-08-04 | 1,400 | $0.00 | 1,400 | $309.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,100 | 2029-04-08 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $750.77 to $751.39, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $751.98 to $752.22, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $753.28 to $753.40, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option, representing a right to purchase a total of 3,500 shares, became exercisable in five equal annual installments beginning on April 8, 2020, which was the first anniversary of the date on which the option was granted.
Billionaire Hedge Funds
